Streptococcal toxic shock syndrome is a severe, rapidly progressing condition requiring structured, prompt clinical management. Selecting the right treatment approach is critical to improving outcomes in this setting.
Management of streptococcal toxic shock syndrome may include plasmapheresis as part of the intervention strategy. The full regimen — including sequencing, indications, supporting measures, and monitoring — is available in the complete protocol.
Plasmapheresis has been proposed, but level of evidence for its use is even smaller than that for IVIG, and only based on isolated cases reports.
DOI: 10.1186/s13613-018-0438-y3/cid/ciu296
View source ↗